BILLIE NIX-BEDDINGFIELD: Open Payments
NPI 1346332517 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,259 in 137 payments from 17 companies in 2025. Trend: 2023 $1,531 · 2024 $1,705 · 2025 $3,259
Food & beverage: $3,259
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 25 | $904 |
| AstraZeneca Pharmaceuticals LP | 16 | $402 |
| Regeneron Healthcare Solutions, Inc. | 12 | $274 |
| Pharming Healthcare, Inc. | 10 | $247 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $246 |
| Amgen Inc. | 13 | $177 |
| CSL Behring | 11 | $172 |
| GlaxoSmithKline, LLC. | 7 | $167 |
| BioCryst US Sales Co., LLC | 9 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $135 |
Products named: DUPIXENT, TEZSPIRE, RUCONEST, NEFFY, AIRSUPRA, ORLADEYO, FASENRA, AYVAKIT.
Industry payments across GA — which companies pay providers there.
